InnovAge director granted 8,539 RSUs

ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/02/2026 - 04:33 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ZORETIC RICHARD C reported acquisition or exercise transactions in this Form 4 filing.

InnovAge Holding Corp. reported that director Richard C. Zoretic received a grant of 8,539 Restricted Stock Units, which will be settled in common stock. These RSUs vest in full on June 30, 2027, contingent on his continued service. After this award, he directly holds 102,349 shares, reflecting routine equity-based compensation rather than an open-market trade.

Insider Trade Summary

Grant/Award: 8,539 shares

Grant/Award 1 txn

Insider ZORETIC RICHARD C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.001 par value	8,539	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.001 par value — 102,349 shares (Direct)

Holdings Before and After: Common Stock, $0.001 par value, 93,810 to 102,349 shares (Direct)

Footnotes (1)

1. F1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.

Key Figures

RSUs granted: 8,539 units Total holdings after transaction: 102,349 shares RSU grant price: $0.0000 per share +1 more

4 metrics

RSUs granted 8,539 units Grant of Restricted Stock Units to director Richard C. Zoretic

Total holdings after transaction 102,349 shares Direct InnovAge common stock holdings following the RSU award

RSU grant price $0.0000 per share Indicates a compensation grant, not a market purchase

Vesting date June 30, 2027 RSUs vest in full on this date, subject to continued service

Key Terms

Restricted Stock Units ("RSUs"), vest in full, grant/award acquisition

3 terms

Restricted Stock Units ("RSUs") financial

"Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in full financial

"and will vest in full on June 30, 2027, subject to the Reporting Person's continued service"

grant/award acquisition financial

"transaction_action": "grant/award acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did InnovAge (INNV) disclose about director Richard C. Zoretic in this Form 4?

InnovAge reported that director Richard C. Zoretic received 8,539 Restricted Stock Units as equity compensation. These units will convert into common shares upon vesting, aligning his interests with shareholders through stock-based rewards instead of cash transactions.

How many RSUs did InnovAge (INNV) grant to Richard C. Zoretic and when do they vest?

InnovAge granted Richard C. Zoretic 8,539 Restricted Stock Units that vest in full on June 30, 2027. Vesting is conditioned on his continued service with the company, encouraging long-term board involvement and alignment with the company’s multi-year performance.

Did Richard C. Zoretic buy or sell InnovAge (INNV) shares in this filing?

He did not buy or sell shares on the open market in this filing. The Form 4 shows an acquisition coded as a grant or award of 8,539 RSUs, representing stock-based compensation rather than a discretionary purchase or sale transaction.

How many InnovAge (INNV) shares does Richard C. Zoretic hold after this RSU grant?

Following the RSU award, Richard C. Zoretic is reported as directly holding 102,349 shares of InnovAge common stock. This total includes the effect of the new grant and provides context for the scale of his equity stake in the company.

What are Restricted Stock Units (RSUs) in the InnovAge (INNV) Form 4?

In this filing, RSUs are promises to deliver InnovAge common shares in the future, subject to vesting conditions. Zoretic’s 8,539 RSUs will convert into shares if he remains in service through June 30, 2027, linking his compensation to future company performance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ZORETIC RICHARD C

(Last) (First) (Middle)

8950 E LOWRY BLVD

(Street)

DENVER COLORADO 80230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InnovAge Holding Corp. [ INNV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value	07/01/2026		A		8,539(1)	A	$0	102,349	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.

Remarks:

	/s/ Nicole D'Amato, by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)